Posted inChinaShanghai

NKY Pharmaceuticals to buy US biotechnology firm

Boai NKY Pharmaceuticals, a Chinese public chemical manufacturing firm known as NKY, is planning to buy San Francisco Bay Area-based biotech firm BioVision, with the aim of focussing on precision medicine, the Shanghai Securities Journal reported. The acquisition will be conducted via NKY Biology, a vehicle specially set up for the planned investment. According to the […]